source
- Endpoints News recaps Boston China biotech debate on industry’s China outlookLast week Endpoints News hosted a live debate in Boston that brought together leading voices in biopharma to discuss China’s growing role in the industry. The panel featured executives and investo…
- Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pillThree years after Robert Hoffman sold XinThera to Gilead, the veteran Pfizer chemist has unveiled his latest venture.Fierce Biotech · 1d ago↗ source
- Definium's LSD-based therapy shows strong Phase 3 results in generalized anxiety disorder